Company	Share, %
Rezolute, Inc.	38.52
Soleno Therapeutics, Inc.	25.93
New Frontier Health Corporation	10.85
Terns Pharmaceuticals, Inc.	10.3
Unicycive Therapeutics, Inc.	9.98
Gracell Biotechnologies Inc.	9.87
Instil Bio, Inc.	9.6
IO Biotech, Inc.	9.37
Bolt Biotherapeutics, Inc.	9.24
Genetron Holdings Limited	8.56
ALX Oncology Holdings Inc.	8.41
Verona Pharma plc	8.2
Compass Therapeutics, Inc.	6.82
Astria Therapeutics, Inc.	5.6
Tarsus Pharmaceuticals, Inc.	5.21
Sera Prognostics, Inc.	5.09
Aligos Therapeutics, Inc.	4.69
Harmony Biosciences Holdings, Inc.	4.59
Geron Corporation	4.41
VectivBio Holding AG	3.72
Kadmon Holdings, Inc.	3.36
Olema Pharmaceuticals, Inc.	3.35
enGene Holdings Inc.	2.93
COMPASS Pathways plc	2.6
Tourmaline Bio, Inc.	2.31
Amyris, Inc.	2.1
Aadi Bioscience, Inc.	2.08
Silence Therapeutics plc	1.7
DBV Technologies S.A.	1.4
Homology Medicines, Inc.	0.64
Delcath Systems, Inc.	0